171 related articles for article (PubMed ID: 328399)
21. Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.
Killion JW; Morrison DC
Infect Immun; 1986 Oct; 54(1):1-8. PubMed ID: 3531011
[TBL] [Abstract][Full Text] [Related]
22. Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.
Johnson W
Infect Immun; 1973 Sep; 8(3):395-400. PubMed ID: 4199718
[TBL] [Abstract][Full Text] [Related]
23. Protective capacity of L-form Salmonella typhimurium against murine typhoid in C3H/HeJ mice.
Nishikawa F; Kita E; Yamada H; Nakano A; Kashiba S
Microbiol Immunol; 1994; 38(2):129-37. PubMed ID: 8041300
[TBL] [Abstract][Full Text] [Related]
24. Antigenic modification, rosette-forming cells, and Salmonella typhimurium resistance in outbred and inbred mice.
Bigley NJ; Kreps DP; Smith RA; Esa A
Infect Immun; 1981 Apr; 32(1):353-63. PubMed ID: 6163728
[TBL] [Abstract][Full Text] [Related]
25. [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].
Schlecht S; Westphal O
Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):71-88. PubMed ID: 44625
[TBL] [Abstract][Full Text] [Related]
26. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium III. Analysis of resistance induced by dialyzable factors.
Kita E; Yasui K; Yasui K; Matsuda Y; Matsuda K; Kashiba S
Microbiol Immunol; 1984; 28(7):807-20. PubMed ID: 6436650
[TBL] [Abstract][Full Text] [Related]
27. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
Venneman MR; Bigley NJ
J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
[TBL] [Abstract][Full Text] [Related]
28. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
Johnson W
Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
[TBL] [Abstract][Full Text] [Related]
29. In vitro stimulation of C3H/HeJ spleen cells and macrophages by a lipid A precursor molecule derived from Salmonella typhimurium.
Vogel SN; Madonna GS; Wahl LM; Rick PD
J Immunol; 1984 Jan; 132(1):347-53. PubMed ID: 6361124
[TBL] [Abstract][Full Text] [Related]
30. Induction of hypersensitivity to endotoxin in C3H/HeJ mice by immunization with L-form Salmonella typhimurium.
Nakano A; Kita E; Yamada H; Kamikaidou N; Kashiba S
Immunol Lett; 1993 Dec; 39(1):77-82. PubMed ID: 7511564
[TBL] [Abstract][Full Text] [Related]
31. Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
Venneman MR; Berry LJ
Infect Immun; 1971 Oct; 4(4):374-80. PubMed ID: 4949497
[TBL] [Abstract][Full Text] [Related]
32. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
[TBL] [Abstract][Full Text] [Related]
33. Localization of the protective antigen in Salmonella typhimurium.
Mates A; Yosipovici H
Microbios; 1976; 16(64):81-90. PubMed ID: 800632
[TBL] [Abstract][Full Text] [Related]
34. LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice.
Wannemuehler MJ; Michalek SM; Jirillo E; Williamson SI; Hirasawa M; McGhee JR
J Immunol; 1984 Jul; 133(1):299-305. PubMed ID: 6202784
[TBL] [Abstract][Full Text] [Related]
35. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
[TBL] [Abstract][Full Text] [Related]
36. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
37. Transfer of Salmonella resistance and delayed hypersensitivity with murine-derived transfer factor.
Smith RA; Esa A; Stiff M
Infect Immun; 1982 Apr; 36(1):271-6. PubMed ID: 7042572
[TBL] [Abstract][Full Text] [Related]
38. Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice.
Eisenstein TK; Killar LM; Stocker BA; Sultzer BM
J Immunol; 1984 Aug; 133(2):958-61. PubMed ID: 6376631
[TBL] [Abstract][Full Text] [Related]
39. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.
Svenson SB; Lindberg AA
Infect Immun; 1981 May; 32(2):490-6. PubMed ID: 6166555
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.
Angerman CR; Eisenstein TK
Infect Immun; 1978 Feb; 19(2):575-82. PubMed ID: 344216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
